By asianet
With the lingering impact of COVID-19 and negative spillover from the situation in Ukraine, the global economy, which has already shown a loss of momentum, is facing uncertainties. Continued fiscal and monetary tightening to bring down inflation in several countries, coupled with supply chain disruptions and decreasing industrial production, further dim global economic prospects. The … Continued
By asianet
— Deal marks Fund’s first investment in Europe and advances its mission of enabling the launch of two to four antimicrobials by 2030 The AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing antimicrobials, announced today that it has invested in BioVersys AG, a clinical-stage company based in Basel, … Continued
By asianet
Aetina, a leading provider of state-of-the-art edge AI solutions, has launched its new NVIDIA® Jetson™-based series of embedded systems and platforms, powered by NVIDIA Jetson Orin NX and Orin Nano™ system-on-modules (SoMs) during the Consumer Electronics Show (CES). These new Aetina DeviceEdge systems and platforms are a set of embedded computers designed for use in … Continued
By asianet
Recently, the promotional video of Fuzhou of Fujian Province, titled “What You Didn’t Know about Fuzhou — a Maritime City”, was released through overseas social media accounts including “Paris Oriental Center”, “Discover Fujian” and “Discover Fuzhou”, showing the world Fuzhou, a Maritime City featuring wisdom, innovation, ecology and prosperity. In the promotional video, Fuzhou’s advanced … Continued
By asianet
– Valeo to utilize C2A’s Cybersecurity DevOps & Automation Platform to scale its cybersecurity software lifecycle management and provide greater security for its customers and modern vehicles Valeo, a leading automotive supplier, and partner to automakers worldwide, and C2A Security [https://c2a-sec.com/], a leading provider of automated cybersecurity solutions for connected, autonomous, and electric vehicles announced … Continued
By asianet
Profet AI (https://www.profetai.com/?lang=en), a Taiwan-based developer of auto machine learning solutions, has raised US$5.6 million in a Series A funding round led by Darwin Ventures. Existing investors Hive Ventures, AUO and SVTI also participated in the round, joined by Harbinger Venture Capital, and Jensen-Capital Management. Profet AI will use this funding to accelerate its overseas … Continued
By asianet
DiscGenics, Inc. ( https://c212.net/c/link/?t=0&l=en&o=3748183-1&h=827169717&u=https%3A%2F%2Fwww.discgenics.com%2F&a=DiscGenics ), a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA on January … Continued
By asianet
– The solution’s fast, neural networks-based low light enhancement capability functions in real time, enabling precision in robotic applications in highly challenging light conditions Inuitive [https://www.inuitive-tech.com/], a leading vision-on-chip processor company, and Visidon, an AI-based image and video enhancement software provider, announced today the release of a high performing, accurate, and real-time low light enhancement … Continued
By asianet
The Chilean Ambassador to India, His Excellency Mr. Juan Angulo Monsalve, recently visited the Athachi Biodiversity Farm at Elappully in Palakkad. Accompanied by his wife, Mr. Angulo spent hours at the farm, understanding its intricacies, and went around the Athachi Nakshatra Vanam, Goshala, and Navagraha Vanam at the farm with great interest. Mr. Raju N … Continued
By asianet
Study met all primary endpoints Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3747842-1&h=3266796279&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3709054-1%26h%3D2795132862%26u%3Dhttps%253A%252F%252Falphynbiologics.com%252F%26a%3DAlphyn%2BBiologics&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today positive results from the first cohort of its Phase 2a clinical trial of AB-101a, a topical therapeutic for mild-to-moderate atopic dermatitis (AD). The trial met all of its primary endpoints, highlighting AB-101a’s potential to be … Continued